REG - Jade Road Investmnts - Results of General Meeting

Jade Road InvestmentsAnnouncement

21/02/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230221:nRSU5020Qa&default-theme=true

RNS Number : 5020Q  Jade Road Investments Limited  21 February 2023

 

21 February 2023

RNS

JADE ROAD INVESTMENTS LIMITED

("Jade Road" or the "Company")

Results of General Meeting

Jade Road is pleased to announce that at the Company's General Meeting held
yesterday, Monday 20 February 2023, all resolutions put to Shareholders were
duly passed.

Following the Company's announcement yesterday at 7:00 am, the Directors have
authorised the allotment of a total of 201,996,350 New Ordinary Shares,
conditional on admission to trading on the AIM market of the London Stock
Exchange plc ("AIM"), comprised of:

·    20,046,667 New Ordinary Shares to placees;

·    171,210,164 New Ordinary Shares to the Underwriter pursuant to its
commitment in the Underwriting Agreement;

·    8,560,508 New Ordinary Shares to the Underwriter in settlement of
underwriting commission pursuant to the terms of the Underwriting Agreement;
and

·    2,179,011 New Ordinary Shares to the Investment Manager as
consideration for services provided under a services agreement between the
‎Company and the Investment Manager, as approved pursuant to a meeting of
the ‎Board on 14 September 2021‎.

Pursuant to the terms of the Underwriting Agreement, a further 1,002,333
Underwriter Warrants have been issued to the Underwriter in settlement of
commission on the Placing Proceeds.

The Underwriting Agreement was entered into between the Company and the
Underwriter on 30 January 2023. Pursuant to the terms of the Underwriting
Agreement, the Underwriter conditionally agreed to underwrite the entirety of
the US$1,750,000 to be raised under the Equity Fundraise for a fee comprising
(i) 5% of an amount equalling US$1,750,000 less the Gross Placing Proceeds, to
be satisfied by the issue of such number of new Ordinary Shares at the Issue
Price as shall equal that amount, and (ii) 5% of the Gross Placing Proceeds,
to be satisfied by the grant of the resulting number of Underwriter Warrants
at an exercise price per Ordinary Share equalling the Issue Price, to be
exercisable over  a three-year period from the date of grant. Details of the
number of Ordinary Shares and Warrants to be issued to the Underwriter are set
out as above. Following the passing of the resolutions at today's General
Meeting, the Underwriting Agreement has now become unconditional.

Admission and Total Voting Rights

Application has been made to AIM for 201,996,350 shares to be admitted to
trading on AIM, the amended admission date is expected to be on or around 24
February 2023.

In accordance with the provision of the Disclosure Guidance and Transparency
Rules of the Financial Conduct Authority, the Company confirms that, following
the issue of the Placing Shares its issued ordinary share capital will
comprise 319,922,023 ordinary shares.

All of the ordinary shares have equal voting rights and 2,647,804 of the
ordinary shares are held in Treasury. The total number of voting rights in the
Company will therefore be 317,274,219. The above figure may be used by
shareholders as the denominator for the calculations to determine if they are
required to notify their interests in, or change to their interest in, the
Company.

Capitalised terms used in this announcement have the meanings ascribed to them
in the announcement of 31 January 2023.

The voting results are available on the website
https://jaderoadinvestments.com/home.

FOR FURTHER INFORMATION, PLEASE CONTACT:

 Jade Road Investment Limited                       +44 (0) 778 531 5588
 John Croft

 Hybridan LLP - Corporate Broker                    +44 (0)203 764 2341
 Claire Noyce

 WH Ireland Limited - Nominated Adviser             +44 (0) 20 7220 1666
 James Joyce
 Andrew de Andrade

 Lionsgate Communications - Communications Adviser  +44 (0) 779 189 2509
 Jonathan Charles

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ROMDGGDDIXDDGXG